What Happened?
Waltham, MA-based Corvidia Appointed Marc Garidel as Chief Executive Officer
About the Company
Corvidia Therapeutics is a biotechnology company pioneering the next generation of cardiovascular therapies. Leveraging functional genomics, the company`s founding team has decoded previously unrecognized genetic susceptibilities within general cardiovascular populations. Corvidia`s pipeline programs precisely identify patients with unique sensitivity to specific biologic pathways, potentially allowing for the rapid development of therapies targeting those pathways. This approach confers unique concepts within the field of cardiovascular medicines and an unprecedented accelerated path-to-market. Corvidia brings together a team of distinguished scientists, experienced drug developers as the management team, and a successful group of investors. Corvidia is headquartered in the Greater Boston area.
About the Person
Marc Garidel is Chief Executive Officer at Corvidia. Previously, Marc held various senior HR leadership roles in the industry.
Info Source
News
Short Profile